Answer
The product is licensed for children aged 6 months and over. The treating team must check specific weight, vascular-access and administration requirements.
Sources for this answer
- Fosaprepitant 150 mg powder for solution for infusion — Current selected SmPCemc · Summary of Product Characteristics
General medicine information. Follow the instructions for your own medicine and speak to a pharmacist or clinician about your individual circumstances.